Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Nicola Davis

Weight-loss jab can cut heart attack and stroke risk in obese adults, firm says

A selection of injector pens for the Wegovy weight loss drug.
Wegovy weightloss injector pens. The study was announced by Novo Nordisk, rather than in a peer-reviewed research paper, so details were limited. Photograph: Jim Vondruska/Reuters

The weight-loss jab Wegovy can reduce the risk of major cardiovascular events by 20% in people who are overweight or obese, the company behind the drug says.

Wegovy – which is not yet available in the UK – has been hailed a wonder drug for weight loss, with the National Institute for Health and Care Excellence (Nice) saying patients on the weekly injections saw their weight fall by an average of 12%, compared with a placebo, after one year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.